Second liver is able to bear or endure medical expert consensus is analytic

Annual March 18 is the whole nation loves liver day , and our country is called hepatitis big country . Interferon and nucleotide (acerbity) analogue is the main treatment method that refuses hepatitis virus treatment at present. Nucleotide (acerbity) the poison of hepatitis B disease-resistant that analogue is profess to convinced treats medicaments, effective and convenient, but use for a long time easy appear be able to bear or endure medicine mutates. One when form recently hepatitis B virus is able to bear or endure medical expert consensus , to be able to bear or endure for clinical doctor and patient the understanding of this one problem mixes drug solution provided a basis definitely. Make consensus reason? Our country is the high popular area of second liver, the hepatitis patient that the whole nation adds newly every year has 100 much, the person that die at hepatitis is made an appointment with 300 thousand, visible, hepatitis already became contagion medium number one killer . In the meantime, our country has the person that virus of liver of 130 million factitious second is carried about, take the in part of electropositive gross of whole world HBsAg almost, among them 1/4 final likelihood develops cirrhosis of chronic hepatitis, liver or liver cancer of former hair sex. However, in treating a process, be able to bear or endure medicine became very a Gordian knot. Current, the remedy that is used at treating hepatitis B basically is interferon and nucleotide (acerbity) analogue. After classics disease-resistant poison is treated, most patient is in hard short-term inside implementation is abiding and respondent, must accept long-term remedy, this is sure to increase disease-resistant poison to be able to bear or endure medical happening risk, increase as what resist virus medicaments sort, hepatitis B virus (HBV) is able to bear or endure the complexity that medicine mutates also will increase greatly. Accordingly, urgent need is able to bear or endure to HBV the relevant concept that medicine mutates and name a method, be able to bear or endure medicine mutates detect method and be able to bear or endure the problem such as the clinical processing after medical mutation happens has a standard, in order to facilitate learning communicates, raise level of clinical make a diagnosis and give treatment. Because at present home still does not have virus of concerned Yu Yi hepatitis,be able to bear or endure the guideline of formulary face, to facilitate the learning between clinical worker communicates, China experiment and magazine of clinical feeling catch a disease (electronic edition) disease of infection of whole nation of editorial office organization learns to reach liver disease to learn a territory famous expert is able to bear or endure to the relevant content that medicine mutates undertook discussion and reach consensus with respect to HBV. Attend consensus the top person that 22 experts that make all are domestic relevant domain, in principle of abide card medicine guidance falls, on the foundation that studies result integration analysis in current and clinical trial, will form on Feburary 16 this year hepatitis B virus is able to bear or endure medical expert consensus . Accordingly, this consensus reflects time going abroad banner level, have very strong authority and representative. Consensus what to say? hepatitis B virus is able to bear or endure medical expert consensus divide in all for 5 parts, introduced hepatitis B virus to be able to bear or endure respectively medical virus learns foundation, nucleotide (acerbity) analogue is able to bear or endure the concept is reached related medical mutation name method, nucleotide (acid) analogue is common be able to bear or endure medicine mutates a virus of dot, hepatitis B be able to bear or endure medicine mutates detect be able to bear or endure with virus of analysis and hepatitis B medicine mutates. Will tell to the clinician, hepatitis B virus is able to bear or endure medical expert consensus the biggest hotspot depends on it having stronger standard gender and practical, to patient occurrence nucleotide (acerbity) analogue is able to bear or endure the processing principle after medicine mutates had a standard, right clinical have directive value with medicine. In the meantime, consensus emphasizes be able to bear or endure not only the clinical processing after medicine, to be able to bear or endure medicine may appear forecasted element and precautionary strategy to also undertake summing up. And to hepatitis B patient, want to decrease be able to bear or endure medical happening, need accomplishs the following. Answer above all logical choice uses drug get used to card: Be able to bear or endure to immunity suffer period or the person that be not mobile period HBV to affect, especially the age is lighter person, if do not need to accept immune depressor or change cure to medication, do not suggest to apply nucleotide (acerbity) analogue. Should follow the doctor's advice next on time, full amount takes drug. Patient of chronic hepatitis B should establish the goal of long-term remedy, cannot be eager to hope for success. Consensus where to search? hepatitis B virus is able to bear or endure medical expert consensus publish full text in China experiment and clinical infection ailing magazine (electronic edition) 2008 the 2nd the 1st period, and the video column of magazine CD was made to this consensus content explain accordingly. (the exercitation edits: Plum apricot)